Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Finasteride may cause long-lasting sexual side effects.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Menopause affects hair and skin; more research needed for treatment.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hormones control reproduction and are crucial for body balance.

High testosterone increases heart disease risk in women with PCOS.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

El Síndrome de Ovario Poliquístico causa problemas de piel como acné y es importante reconocerlo temprano para tratarlo.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.